Huller Kelly
EVP, GC, Corporate Secretary
Huller Kelly has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 27, 2026.
On the most recent filing, Huller Kelly is listed as EVP, GC, Corporate Secretary at GLOBUS MEDICAL INC. Inside the rolling window, Huller Kelly reported no open-market purchases and 3 open-market sales totaling $3.4M in GMED. The largest disclosed transaction in the window is a sale of 20,000 GMED shares on Feb 25, 2026, worth $1.9M.
Companies traded
Other insiders at GMED
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Huller Kelly made?
Huller Kelly has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Huller Kelly trade?
Huller Kelly has filed SEC Form 4 disclosures for 1 company, including GMED.
When was Huller Kelly's most recent SEC Form 4 filing?
Huller Kelly's most recent SEC Form 4 filing on Tracefour is dated Feb 27, 2026.
What is Huller Kelly's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Huller Kelly is listed as EVP, GC, Corporate Secretary.
What is Huller Kelly's total buy and sell value in the current window?
Inside the rolling retention window, Huller Kelly bought $0 and sold $3.4M based on SEC Form 4 filings.
What was Huller Kelly's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 20,000 GMED shares on 2026-02-25, worth $1.9M, per SEC Form 4 filings.